Prescribing SGLT2 Inhibitors in Patients With CKD: Expanding Indications and Practical Considerations-Reference-Cited by-同舟云学术

Prescribing SGLT2 Inhibitors in Patients With CKD: Expanding Indications and Practical Considerations

Published:2022-11 Issue:11 Volume:7 Page:2546-2547
ISSN:2468-0249
Container-title:Kidney International Reports
language:en
Short-container-title:Kidney International Reports

Author:

Yau Kevin,Dharia Atit,Alrowiyti Ibrahim,Cherney David Z.I.

Publisher

Elsevier BV

Subject

Nephrology

Reference10 articles.

1. Letter regarding “prescribing SGLT2 inhibitors in patients with CKD: expanding indications and practical considerations”;Rico-Fontalvo;Kidney Int Rep,2022

2. Effects of dapagliflozin in DAPA-HF according to background heart failure therapy;Docherty;Eur Heart J,2020

3. Dapagliflozin and diuretic use in patients with heart failure and reduced ejection fraction in DAPA-HF;Jackson;Circulation,2020

4. A comparative study of safety outcomes of sodium glucose cotransporter-2 inhibitors and loop diuretics among diabetic patients using real-world data;Rahhal;Curr Probl Cardiol,2021

5. Effects of canagliflozin on cardiovascular, renal and safety outcomes by baseline loop diuretic use: data from the credence trial;Neuen;J Am Coll Cardiol,2020

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autonomic modulation by SGLT2i or DPP4i in patients with diabetes favors cardiovascular outcomes as revealed by skin sympathetic nerve activity;Frontiers in Pharmacology;2024-07-30

2. Focal Segmental Glomerulosclerosis;Advances in Kidney Disease and Health;2024-07

3. The Renoprotective Mechanisms of Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i)—A Narrative Review;International Journal of Molecular Sciences;2024-06-27

4. Euglycemic ketoacidosis associated with SGLT2 inhibitors and DPP4 inhibitors - discussion of case reports;Anesteziologie a intenzivní medicína;2024-06-24

5. Pathogenesis of euglycemic ketoacidosis associated with SGLT2 inhibitors;Anesteziologie a intenzivní medicína;2024-06-24